Abstract
There is an obvious need to develop efficient countermeasure agents for use in emergency situations or as adjuncts to radiotherapy to protect healthy tissues from the consequences of an irradiation. To this end, we have investigated the capacity of norbadione A, a polyphenol extracted from the edible mushroom Bay boletus to reduce the toxicity of ionizing radiation towards cultured cells and whole-body exposed mice. Results indicate that this compound could slightly enhance the resistance of TK6 lymphoid cells to radiation and increase the survival rate in lethally irradiated mice. However, norbadione A was found to be cytotoxic at concentrations over 30 μM in vitro. The acute toxicity of this compound also precluded its use at higher doses for enhanced in vivo radioprotection. Norbadione A may nevertheless serve as lead for development of less toxic analogs with potentially cytoprotective/radioprotective activities.
Keywords: Norbadione A, Polyphenol, Radioprotective agent, Lymphocytes, radioprotective, polyphenol norbadione A, TK6, Fukushima's nuclear plant, conventional radiotherapy, sulfhydryl compounds, experimental radioprotective arsenal, reactive oxygen species (ROS), Resveratrol, Xerocomus badius
Letters in Drug Design & Discovery
Title: Evaluation of the Radioprotective Potential of the Polyphenol Norbadione A
Volume: 9 Issue: 1
Author(s): Antoine Le Roux, Elodie Josset, Sami Benzina, Brice Nadal, Marine Desage-El Murr, Benoit Heurtaux, Frederic Taran, Jean-Marc Denis, Thierry Le Gall, Stephane Meunier and Pierre Bischoff
Affiliation:
Keywords: Norbadione A, Polyphenol, Radioprotective agent, Lymphocytes, radioprotective, polyphenol norbadione A, TK6, Fukushima's nuclear plant, conventional radiotherapy, sulfhydryl compounds, experimental radioprotective arsenal, reactive oxygen species (ROS), Resveratrol, Xerocomus badius
Abstract: There is an obvious need to develop efficient countermeasure agents for use in emergency situations or as adjuncts to radiotherapy to protect healthy tissues from the consequences of an irradiation. To this end, we have investigated the capacity of norbadione A, a polyphenol extracted from the edible mushroom Bay boletus to reduce the toxicity of ionizing radiation towards cultured cells and whole-body exposed mice. Results indicate that this compound could slightly enhance the resistance of TK6 lymphoid cells to radiation and increase the survival rate in lethally irradiated mice. However, norbadione A was found to be cytotoxic at concentrations over 30 μM in vitro. The acute toxicity of this compound also precluded its use at higher doses for enhanced in vivo radioprotection. Norbadione A may nevertheless serve as lead for development of less toxic analogs with potentially cytoprotective/radioprotective activities.
Export Options
About this article
Cite this article as:
Le Roux Antoine, Josset Elodie, Benzina Sami, Nadal Brice, Desage-El Murr Marine, Heurtaux Benoit, Taran Frederic, Denis Jean-Marc, Le Gall Thierry, Meunier Stephane and Bischoff Pierre, Evaluation of the Radioprotective Potential of the Polyphenol Norbadione A, Letters in Drug Design & Discovery 2012; 9 (1) . https://dx.doi.org/10.2174/157018012798192900
DOI https://dx.doi.org/10.2174/157018012798192900 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biological Basis of Novel Therapies for Myelodysplastic Syndrome
Current Cancer Therapy Reviews Anticancer α-Helical Peptides and Structure / Function Relationships Underpinning Their Interactions with Tumour Cell Membranes
Current Protein & Peptide Science Mechanism and Anticancer Activity of the Metabolites of an Endophytic Fungi from Eucommia ulmoides Oliv
Anti-Cancer Agents in Medicinal Chemistry A Guide to Treatment of Sarcoidosis
Current Drug Therapy Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance
Current Cancer Drug Targets Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety
Current Medicinal Chemistry Chemogenomic Approaches for the Exploration of GPCR Space
Current Topics in Medicinal Chemistry Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Anti-Angiogenesis in Glioblastoma: The Clinical Consequences of Redundancy and Evasion?
Current Angiogenesis (Discontinued) Synthetic Lipoproteins as Carriers for Drug Delivery
Current Medicinal Chemistry MicroRNA and Cancer: Tiny Molecules with Major Implications
Current Genomics Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas
Current Drug Discovery Technologies Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology
Current Pharmaceutical Design Notch-Associated MicroRNAs in Cancer
Current Drug Targets Editorial:Genomics and Epigenomics of Tumor and Aging Cells
Current Genomics Leukopenia Associated with Risperidone Treatment
Current Drug Safety Mucoadhesive Nanoparticulate System for Oral Drug Delivery: A Review
Current Drug Therapy Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
Current Topics in Medicinal Chemistry Insights into the Microbial L-Asparaginases: from Production to Practical Applications
Current Protein & Peptide Science